CH₃CH₃
AI image · google/nano-banana-2-lite
official

Cenexa Labs: the retatrutide vial that became GLP3, and the two Wyoming companies Lilly sued

by ch3ch3 · 3d ago · 0 comments

Vendor active also CenexaLabs, Cenexa, Cenexa Labs LLC, P2T2 Holdings LLC, P2T2 Inc. cenexalabs.com
C
#26 of 54 vendors audit better than 56% of them · what people say 50/100
Our grade serious findings
57/ 100

scored on 10 of 12 criteria · 2 could not be told

Readers’ grade no ratings yet
  • Accuracy –
  • Delivery –
  • Service –
  • Honesty –
  • Overall –

Be the first. The form below takes about twenty seconds and needs no account.

The score above weighs both: ours is what the record shows, theirs is what people who dealt with this entity say.

  • Is there an identifiable legal operator: a registered name, a jurisdiction, an address that resolves?

    the site names no company; Lilly named two different Wyoming LLCs in two complaints; the terms name P2T2 Inc. for e-checks; the site claims Texas, gives a Jackson, Wyoming suite and writes its terms under Nevada law

    Evidence: [5][7][6][3][2]

  • How long has it operated, by evidence: first archive capture, domain registration, oldest attributable post?

    first LLC June 2025, domain September 2025, products from November 2025; about a year of trading

    Evidence: [5][8][9][10]

  • Does it publish third-party certificates of analysis for what it sells?

    certificates are published; two read, from two different labs, neither stating an accreditation; the site says accredited labs test every batch

    Evidence: [20][15][4][7]

  • Where there are results, do they agree with the label, the marketing and the reported effects?

    the two certificates read agree with their labels; the retatrutide certificate was not available to read

    Evidence: [20][15]

  • Are contents and amounts stated on the product?

    vials state an amount; from spring 2026 the retatrutide and tirzepatide vials carry code names, GLP3-RT and GLP2-TZ, in place of the compound

    Evidence: [9][12]

  • No disease claims, no 'safe', no borrowed botanical names for synthetic compounds?

    Lilly's trial results and a Lilly executive on the product page, per the complaint; a reviews page that pays for reviews and asks buyers to leave out human use

    Evidence: [7][19][10]

  • Pattern of complaints about orders not arriving, long delays, no tracking?

    no buyer thread found in r/Peptides or r/Retatrutide

    Evidence: [18]

  • Pattern of complaints about wrong, inert, contaminated or mislabelled product?

    no buyer thread found in r/Peptides or r/Retatrutide

    Evidence: [18]

  • Chargebacks refused, refunds unanswered, processors dropped?

    no returns and no refunds; cards, e-check, Klarna and cryptocurrency

    Evidence: [4][3]

  • Warning letters, seizures, lawsuits, attorney-general actions, platform bans?

    a pending federal suit by Eli Lilly (allegations, untried); no FDA warning letter under either name

    Evidence: [5][7][21][22][23]

  • Is there any attempt to keep minors out?

    21 and over, by a one-click box with a research-use attestation

    Evidence: [11][3]

  • Does it say what the legal status of what it sells is, honestly, where it ships?

    research use only on an unapproved drug, sold under a code name, beside a request that reviewers not mention human use

    Evidence: [11][19][7]

Operating since
at least 2025-06-20 (the first Wyoming LLC named by Lilly was organized 2025-06-20; the domain was registered 2025-09-02; product images were uploaded from November 2025; first archived storefront 2026-03-20)
Where
a family-owned business based in Texas (the About page, archived May 2026); 680 S Cache Street, Suite 100-8790, Jackson, Wyoming (the contact page, archived October 2026); ships from a Texas warehouse or a Georgia warehouse (the FAQ, archived August 2026)
Verified
every quotation checked against its document on 2026-11-18; 23 sources

What they sell, and what we think is in it

  • Retatrutide 5 mg, renamed GLP3 (vial label GLP3-RT) Peptides a triple-receptor agonist Retatrutide
  • GLP3 + Cagrilintide Blend Peptides The Four-Pathway Metabolic Research Compound Retatrutide with cagrilintide, an investigational amylin analogue
  • Tirzepatide 5 mg, renamed GLP2 (vial label GLP2-TZ) Peptides Tirzepatide Tirzepatide
  • Orforglipron (capsules) Research chemicals Orforglipron is an oral small-molecule GLP-1 agonist studied for metabolic research orforglipron, the active ingredient of Lilly's oral obesity drug Foundayo
  • Mazdutide Peptides Mazdutide is a dual-action synthetic peptide studied for obesity and diabetes research mazdutide, an investigational GLP-1 and glucagon receptor agonist
  • KLOW Blend (BPC-157+TB-500+GHK-Cu+KPV) Peptides KLOW Blend (BPC-157+TB-500+GHK-Cu+KPV) BPC-157 with TB-500, GHK-Cu and KPV
  • Cerebrolysin 60 mg Peptides Cerebrolysin (peptide hydrolysate / peptide fragment mixture) a peptide mixture, as the certificate describes it
  • Enclomiphene Capsules Other Enclomiphene Capsules enclomiphene, a non-steroidal estrogen receptor modulator

Molecules named in this dossier

Pulse what people say about Cenexa Labs

✓ 0 good 0 bad ✕

One tap, no account. Then for up to 36 Methyls.

The long read

Who they say they are, and what the record says

Cenexa Labs sells peptides from a website at cenexalabs.com. Its About page calls it a "family-owned business based in the great state of Texas" and says "we started on the B2B side of peptides".⁠[1] Its contact page gives a different state: "680 S Cache Street, Suite 100-8790, Jackson, WY 83001", next to the words "Family-owned, Texas-based, and researcher-first".⁠[2] Its terms of use are "governed by and construed in accordance with Nevada law".⁠[3] The FAQ says "All our orders ship from either our Texas warehouse or our Georgia warehouse".⁠[4]

The site names no company. The only legal name we found on it is in the terms: "All e-Check/ACH payments will be made payable to P2T2 Inc."⁠[3] That line is already in the earliest archived copy of the terms, March 2026.

Eli Lilly and Company has named two different Wyoming companies as the business behind the site. The facts below are Lilly's, from its pleadings. We could not check them against the Wyoming register.

  • The first complaint, 8 October 2026, sued "Defendant Cenexa Labs LLC, doing business as Cenexa Labs". It describes a company organized on 20 June 2025 under "Wyoming Secretary of State filing number 2025-001704310", whose registered agent and principal office are both at "30 N Gould St, Ste R, Sheridan, WY 82801".⁠[5] Lilly's disclosure of interested parties on 21 October gave the same company the contact-page address, 680 S "Cache Street, Suite 100-8790, Jackson, WY 83001".⁠[6]
  • The amended complaint, 2 November 2026, sues "Defendant P2T2 Holdings LLC, doing business as Cenexa Labs" instead. That company was organized on 23 September 2025 under "Wyoming Secretary of State filing number 2025-001774498". Its principal office is "680 S Cache Street, Suite 100-6949, Jackson, Wyoming". That is the same street address as the website's but a different suite. Its registered agent is in Jackson too. "Upon information and belief, its sole member(s) is a citizen of" Texas, Lilly says. Lilly also notes that the store's telephone number has "a Houston, Texas area code".⁠[7]

Page 1 of the amended complaint, case 4:26-cv-08806, filed 11/02/26 in the Southern District of Texas, Houston Division: Eli Lilly and Company, Plaintiff, v. P2T2 Holdings LLC d/b/a Cenexa Labs, Defendant. Footnote 1 says Cenexa appears to have recently removed its retatrutide products from its website.
Figure 1. The amended complaint of 2 November 2026. The defendant changes from Cenexa Labs LLC to P2T2 Holdings LLC, and footnote 1 records that the retatrutide products are gone from the site.⁠[7]

So the record has two LLCs three months apart, plus a "P2T2 Inc." on the site's terms. The amended complaint does not say why the defendant changed. A plaintiff correcting the name of the business it sued is a fact of the docket, not a finding about anyone.

The domain was registered on 2 September 2025, between the two Wyoming filings.⁠[8] The retatrutide product image on the site was uploaded in November 2025.⁠[9] The first archived copy of the storefront is from 20 March 2026.⁠[10]

What they sell

The home page sells the store as a maker, not a reseller. "Unlike most peptide sites who simply resell vials from underground chinese labs, we produce our own." A panel under it is headed "Manufacturer, Not Reseller".⁠[10] We found nothing that names a facility or an inspection behind that claim. The footer has a link titled "Peptide Sciences Alternative", which uses the name of another peptide vendor.⁠[10]

The catalogue is research peptides, blends, "bioregulators", capsules, nasal sprays and topicals. This dossier is about the part Lilly sued over: the GLP-1 class of weight-loss drugs.

Retatrutide, then "GLP3". In March 2026 the home page's list of popular products included "Retatrutide" and "Tirzepatide".⁠[10] By 6 May the same two slots read "GLP3" and "GLP2".⁠[11] The product images show what changed. The vial pictured as Retatrutide, stock code PEP-RET-5, was re-uploaded with the same stock code and a label reading GLP3-RT.⁠[9][12] Tirzepatide's vial, PEP-TIR-5, became GLP2-TZ the same way. Retatrutide is Lilly's investigational triple agonist and is approved nowhere. Tirzepatide is the active ingredient of Lilly's Mounjaro and Zepbound.⁠[7]

A product image of a 5 mg glass vial with a navy cap. The label reads Cenexa Labs, Retatrutide, Triple Agonist, 5 MG. Above it are three round badges: Made in USA, Guarantee Cenexra Pure, and 3rd Party Lab Tested.
Figure 2. The retatrutide vial as the store pictured it in March 2026. The file is named Retatrutide_5mg_PEP-RET-5 and was uploaded in November 2025.⁠[9]

The same vial image with the same badges, cap and 5 MG flag. The label now reads GLP3-RT, Triple Agonist, in place of Retatrutide.
Figure 3. May 2026: the same vial and the same stock code, PEP-RET-5, with the label changed to GLP3-RT. The tirzepatide vial became GLP2-TZ the same way.⁠[12]

The GLP3 page itself was never archived, so what it said comes from Lilly's complaint. According to the amended complaint, the page called the product "LY3437943, GLP-3, and GLP3-R", which includes Lilly's own development code. It described the product as "a triple-receptor agonist", and its certificate of analysis, dated 1 June 2026, named the compound "Retatrutide (GLP3)". Lilly says the store also sold a "GLP3 + Cagrilintide Blend" as "The Four-Pathway Metabolic Research Compound", and a buy-one-get-one offer on "GLP3 vials with a limit of 3 per customer".⁠[7]

Other weight-loss compounds. In August 2026 the store listed orforglipron as a capsule: "Orforglipron is an oral small-molecule GLP-1 agonist studied for metabolic research".⁠[13] Orforglipron is the active ingredient of Foundayo, the oral obesity drug FDA approved for Lilly on 1 April 2026.⁠[7] The store's page files it under Peptide Capsules and then says "Orforglipron is a nonpeptide small molecule delivered as a once-daily oral pill".⁠[13] In October it listed mazdutide: "Mazdutide is a dual-action synthetic peptide studied for obesity and diabetes research".⁠[14]

The rest. Blends such as the "KLOW Blend (BPC-157+TB-500+GHK-Cu+KPV)" sat in the same popular list.⁠[10] A certificate on the site covers "Cerebrolysin (peptide hydrolysate / peptide fragment mixture)".⁠[15] In October 2026 the shop listed "Enclomiphene Capsules".⁠[16] Lilly's complaint points to the capsules, sprays and topicals, "including peptide capsules, nasal sprays, and topical peptides", as formats a research laboratory would not need.⁠[7]

What was removed. In late September the shop page still had a GLP category and a footer link to "GLP Peptides".⁠[17] By 27 October, after the first complaint, both were gone.⁠[16] The amended complaint says: "It appears that Cenexa has recently removed its retatrutide products from its website".⁠[7] Its wording also changes from "Cenexa markets and sells weight-management products"⁠[5] to "Cenexa marketed and sold weight-management products".⁠[7]

What buyers report

We searched the Arctic Shift archive of Reddit on 18 November 2026. Since 1 September 2025, r/Peptides has 18,427 posts, and none names Cenexa. r/Retatrutide has 20,000 posts since 7 June 2026, and none names it either.⁠[18] With no buyer threads to read, delivery and quality are scored unknown.

The site carries its own praise. Every page says "Over 18,000 Happy Customers".⁠[10] The VIP reviews page offers "$5 In Cenexa Bucks to tell your story", and it asks for something in return: "keep your review focused on the VIP program features", "not on research applications or human use". It explains: "That keeps our community compliant and our doors open."⁠[19] Lilly cites this page: "Cenexa specifically asks customers to avoid mentioning they are using its" products for human use.⁠[7] The store's own reviews are paid for in store credit and asked to leave out the use of the product, so they are not evidence about the product.

Part of the store's VIP reviews page. A shaded line reads: One ask: Since Cenexa is RUO-only, keep your review focused on the VIP program features, shipping, savings, priority access, rewards, not on research applications or human use. That keeps our community compliant and our doors open. Below it is a Leave a Review form.
Figure 4. The VIP reviews page in August 2026. It pays store credit for a review and asks reviewers to leave out human use.⁠[19]

Lab results

The FAQ says "Every batch is tested by accredited independent labs".⁠[4] The About page says "Independent labs verify purity by HPLC/MS, check for heavy metals" and checks for solvents and microbes too.⁠[1] The site also publishes certificates. We read the two that were archived.

  • KLOW blend, 80 mg, lot L2505-008. Bioviridian Inc. issued certificate COA2796 on 4 February 2026. It identifies BPC-157, TB-500, KPV and GHK-Cu by mass spectrometry and reports 9.87, 10.31, 11.34 and 51.43 mg. The vial in the certificate's photograph is labelled 10/10/10/50 mg, so every amount is within 14% of the label, and purity is given as 99.6%.⁠[20] The photographed vial also carries a sticker reading QC260295. The certificate does not say how that number relates to the lot number.
  • Cerebrolysin, 60 mg, lot L2504-026. This certificate, BS12652, is dated 15 December 2025. It reports a "Total Peptide Content (OPA/BCA/AAA)" of 62.4 mg against a 60 mg label. It also reports sterility and endotoxins. The issuer is a laboratory called BioSyn: "This COA confirms that the tested material meets or exceeds BioSyn" specifications.⁠[15]

A one-page certificate of analysis headed Bioviridian, Excellence in HPLC-MS Analysis, COA2796, issued February 4, 2026, for vendor Cenexa Labs, sample Klow blend 80mg, lot L2505-008. It reports identity of BPC-157, TB-500, KPV and GHK-Cu by MALDI-MS, contents 9.87, 10.31, 11.34 and 51.43 mg, and purity 99.6%, with a chromatogram, two mass spectra and a photo of a vial labelled KLOW 10/10/10/50 MG.
Figure 5. One of the two certificates read: Bioviridian's February 2026 analysis of the KLOW blend. The four amounts sit within 14% of the 10/10/10/50 mg on the vial.⁠[20]

The two certificates come from two different laboratories, and neither states an accreditation. Both agree with their labels. The retatrutide certificate, which Lilly says named "Retatrutide (GLP3)", was not archived.⁠[7] This site holds no independent test of a Cenexa product.

Regulatory and legal

Eli Lilly and Company v. Cenexa Labs LLC, No. 4:26-cv-08806 (S.D. Tex.). Lilly sued on 8 October 2026.⁠[5][21] The claims are under state unfair-competition and consumer-protection law. Lilly argues that an unapproved drug sold for human use is an illegal sale, whatever the label says. The case is part of our tracker of Lilly's retatrutide suits, which covers the legal theory and the other defendants.

The amended complaint of 2 November makes these allegations, which have not been tested in court:

  • Lilly's trial results on the product page. According to Lilly, the store "extensively cited" Lilly's trial data, including a "[m]ean weight loss of 24.2% (approximately 58 pounds" at the top dose.⁠[7]
  • A Lilly scientist. The product page ran a "Lead Researcher Spotlight" on a Lilly research executive, the company's "Associate Vice President of Diabetes Research", with a line disclaiming any affiliation. Lilly says the spotlight "is designed to lend the appearance of scientific legitimacy" to the product.⁠[7] We give his title and not his name: he is not a party.
  • Research use only as a pretext. Lilly argues that the subscription discounts, the buy-one-get-one offer, the "Cenexa Bucks" rewards and the reviews page show sales for human use.⁠[7]

The store's own pages put research use on every page. The age gate makes the visitor tick "I understand these products are for research use only and not for use in people or pets."⁠[11] The terms say "The purchaser warrants that they are affiliated with a laboratory".⁠[3] The FAQ adds: "No formal documentation is required to purchase".⁠[4] The contact page says "Any inquiries relating to human or animal peptide use will be ignored."⁠[2]

The documents filed in the case that are available through RECAP on 18 November 2026 are Lilly's three: the complaint, the disclosure and the amended complaint. None is from the defendant.⁠[21]

FDA. On 18 November 2026 we searched FDA's warning-letter index for "Cenexa" and "P2T2". Neither returned a letter.⁠[22] On 24 August 2026 FDA's drug centre sent warning letters to five online peptide vendors, "alleging that each sold unapproved new drugs".⁠[23] Cenexa was not one of the five.

Age. The site uses a one-click box: "You must be at least 21 to visit this site."⁠[11] The terms say "MUST be at least 21 years of age to purchase".⁠[3]

Payment. The FAQ lists "Credit Cards, eCheck/ACH, Klarna and a variety of Crypto Currencies". On returns it says "we cannot accept returns and do not offer refunds".⁠[4] The disclaimer says "Waave Compliance blocks all international shipping"; Waave is a payment processor.⁠[11]

Still open

  • Who owns it. Lilly's pleadings name two Wyoming LLCs. The site's terms name a P2T2 Inc. We found no state record that ties a person or a Texas company to either LLC.
  • The manufacturing claim. "We produce our own" names no facility. We found no registration or inspection record behind it.
  • Delivery and quality. No buyer thread in r/Peptides or r/Retatrutide names the store. Both verdicts stay unknown until buyers' reports appear.
  • The retatrutide certificate. The 1 June 2026 certificate that Lilly quotes was not archived, so we have not read it.

Changes

2026-11-18: first published.

References

  1. CenexaLabs.com, About, archived 2026-05-06 — Wayback Machine
  2. CenexaLabs.com, Contact, archived 2026-10-27 — Wayback Machine
  3. CenexaLabs.com, Terms of Use, archived 2026-03-20 — Wayback Machine
  4. CenexaLabs.com, FAQ, archived 2026-08-13 — Wayback Machine
  5. Eli Lilly and Company v. Cenexa Labs LLC, No. 4:26-cv-08806 (S.D. Tex.), complaint (ECF 1), filed 2026-10-08 — US District Court, S.D. Tex., via CourtListener RECAP
  6. Eli Lilly and Company v. Cenexa Labs LLC, Plaintiff's Disclosure of Interested Parties (ECF 7), filed 2026-10-21 — US District Court, S.D. Tex., via CourtListener RECAP
  7. Eli Lilly and Company v. P2T2 Holdings LLC d/b/a Cenexa Labs, No. 4:26-cv-08806 (S.D. Tex.), amended complaint (ECF 9), filed 2026-11-02 — US District Court, S.D. Tex., via CourtListener RECAP
  8. RDAP record for cenexalabs.com (registered 2025-09-02, Cloudflare, registrant redacted), read 2026-11-18 — Verisign
  9. CenexaLabs.com product image Retatrutide_5mg_PEP-RET-5 (uploaded 2025/11), archived 2026-03-20 — Wayback Machine
  10. CenexaLabs.com home page, archived 2026-03-20 (the first capture of the storefront) — Wayback Machine
  11. CenexaLabs.com home page, archived 2026-05-06 — Wayback Machine
  12. CenexaLabs.com product image GLP3-RT_5mg_PEP-RET-5, archived 2026-05-06 — Wayback Machine
  13. CenexaLabs.com, Orforglipron product page (Peptide Capsules), archived 2026-08-13 — Wayback Machine
  14. CenexaLabs.com, Mazdutide product page, archived 2026-10-02 — Wayback Machine
  15. Certificate of analysis BS12652, Cerebrolysin 60 mg, lot L2504-026, issued 2025-12-15, as published by the store (archived 2026-05-06) — Wayback Machine
  16. CenexaLabs.com, Shop, archived 2026-10-27 — Wayback Machine
  17. CenexaLabs.com, Shop, archived 2026-09-24 — Wayback Machine
  18. r/Peptides posts 2025-09-01 to 2026-11-18 (18,427) and r/Retatrutide posts 2026-06-07 to 2026-11-18 (20,000), through the Arctic Shift archive, searched for 'cenexa' on 2026-11-18: no match — Arctic Shift — anecdotal report, not evidence
  19. CenexaLabs.com, Cenexa VIP Program Reviews, archived 2026-08-13 — Wayback Machine
  20. Certificate of analysis COA2796, KLOW blend 80 mg, lot L2505-008, Bioviridian Inc., issued 2026-02-04, as published by the store (archived 2026-03-20) — Wayback Machine
  21. Docket, Eli Lilly and Company v. Cenexa Labs LLC, 4:26-cv-08806 (S.D. Tex.); RECAP document store checked 2026-11-18 (documents 1, 7 and 9 only) — CourtListener (RECAP)
  22. FDA warning-letter index searched for 'cenexa' and 'P2T2', 2026-11-18 (no results; the same query for 'peptide partners' returns one letter) — U.S. Food and Drug Administration
  23. RUO-ined: Five Peptide Vendors Learn That 'Research Use Only' Is Not a Legal Strategy — ArentFox Schiff
0

What readers say

Anyone can rate here, with or without an account. One rating per person; a second submission edits the first.

Readers’ grade no ratings yet
  • Accuracy –
  • Delivery –
  • Service –
  • Honesty –
  • Overall –

Be the first. The form below takes about twenty seconds and needs no account.

Rate Cenexa Labs

One to five on each. Your experience, not a verdict on the record; our own grade is separate.

AccuracyIt was what it said it was
DeliveryIt arrived, when it should have
ServiceQuestions and problems were answered
HonestyLabels and results told the truth
OverallOverall trust
0/600
Posting as guest

Comments

Sign in to join the conversation.

No comments yet.

Tell us something